BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2411217)

  • 1. Biochemical mechanisms of the antileishmanial activity of sodium stibogluconate.
    Berman JD; Waddell D; Hanson BD
    Antimicrob Agents Chemother; 1985 Jun; 27(6):916-20. PubMed ID: 2411217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry of Pentostam resistant Leishmania.
    Berman JD; Edwards N; King M; Grogl M
    Am J Trop Med Hyg; 1989 Feb; 40(2):159-64. PubMed ID: 2537584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes.
    Berman JD; Gallalee JV; Best JM
    Biochem Pharmacol; 1987 Jan; 36(2):197-201. PubMed ID: 3028425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania spp.: development of pentostam-resistant clones in vitro by discontinuous drug exposure.
    Grögl M; Oduola AM; Cordero LD; Kyle DE
    Exp Parasitol; 1989 Jul; 69(1):78-90. PubMed ID: 2543590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals.
    Mottram JC; Coombs GH
    Exp Parasitol; 1985 Apr; 59(2):151-60. PubMed ID: 2982638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antileishmanial activity of sodium stibogluconate fractions.
    Roberts WL; Rainey PM
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1842-6. PubMed ID: 8239593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam).
    Berman JD; Grogl M
    Exp Parasitol; 1988 Oct; 67(1):96-103. PubMed ID: 2844580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo antileishmanial properties of pentavalent antimonial compounds.
    Neal RA; Matthews PJ
    Trans R Soc Trop Med Hyg; 1982; 76(2):284. PubMed ID: 6285557
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro antileishmanial properties of tri- and pentavalent antimonial preparations.
    Roberts WL; Berman JD; Rainey PM
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1234-9. PubMed ID: 7574507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.
    Martinez S; Looker DL; Berens RL; Marr JJ
    Am J Trop Med Hyg; 1988 Sep; 39(3):250-5. PubMed ID: 2845824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes.
    Ephros M; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1997 May; 41(5):1064-8. PubMed ID: 9145870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania mexicana: purine metabolism in promastigotes, axenic amastigotes, and amastigotes derived from Vero cells.
    Hansen BD; Webster HK; Hendricks LD; Pappas MG
    Exp Parasitol; 1984 Aug; 58(1):101-9. PubMed ID: 6745384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of antileishmanial agents against amastigotes in human monocyte-derived macrophages and in mouse peritoneal macrophages.
    Berman JD; Lee LS
    J Parasitol; 1984 Apr; 70(2):220-5. PubMed ID: 6088749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani.
    Chakraborty AK; Majumder HK
    Biochem Biophys Res Commun; 1988 Apr; 152(2):605-11. PubMed ID: 2835038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania donovani: isolation and characterization of sodium stibogluconate (Pentostam)-resistant cell lines.
    Ullman B; Carrero-Valenzuela E; Coons T
    Exp Parasitol; 1989 Aug; 69(2):157-63. PubMed ID: 2546793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene amplification in Leishmania tarentolae selected for resistance to sodium stibogluconate.
    Haimeur A; Ouellette M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1689-94. PubMed ID: 9661005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary agent for leishmaniasis.
    Berman JD
    Am J Trop Med Hyg; 1988 May; 38(3):652. PubMed ID: 2856321
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
    Nabors GS; Farrell JP
    Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of formycin B on mRNA translation and uptake of purine precursors in Leishmania mexicana.
    Nolan LL; Berman JD; Giri L
    Biochem Int; 1984 Aug; 9(2):207-18. PubMed ID: 6207832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimony susceptibility of Leishmania isolates collected over a 30-year period in Algeria.
    Eddaikra N; Ait-Oudhia K; Kherrachi I; Oury B; Moulti-Mati F; Benikhlef R; Harrat Z; Sereno D
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006310. PubMed ID: 29561842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.